VX-150 structure
|
Common Name | VX-150 | ||
|---|---|---|---|---|
| CAS Number | 1793080-72-4 | Molecular Weight | 516.34 | |
| Density | 1.59±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C21H17F4N2O7P | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of VX-150VX-150 is an orally active, highly selective NaV1.8 inhibitor. VX-150 has the potential for various pain indications research[1]. |
| Name | VX-150 |
|---|---|
| Synonym | More Synonyms |
| Description | VX-150 is an orally active, highly selective NaV1.8 inhibitor. VX-150 has the potential for various pain indications research[1]. |
|---|---|
| Related Catalog | |
| Target |
Nav1.8 |
| In Vitro | VX-150 is an orally bioavailable pro-drug that rapidly converts into its active moiety, which is a highly selective inhibitor of NaV1.8 relative to the other sodium channel subtypes (>400-fold)[1]. |
| References |
| Density | 1.59±0.1 g/cm3 |
|---|---|
| Molecular Formula | C21H17F4N2O7P |
| Molecular Weight | 516.34 |
| Storage condition | -20°C |
| (4-(2-(4-fluoro-2-methylphenoxy)-4-(trifluoromethyl)benzamido)-2-oxo-1l4,2l5-pyridin-1-yl)methyldihydrogenphosphate |